CN Stock MarketDetailed Quotes

Hybio Pharmaceutical (300199)

Watchlist
  • 23.64
  • -0.28-1.17%
Trading May 20 11:05 CST
20.88BMarket Cap220.93P/E (TTM)

Hybio Pharmaceutical (300199) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Raw material medicine438.09M45.33%
Preparation430.19M44.52%
Other business38.63M4.00%
Customer peptide28.58M2.96%
Solid class27.35M2.83%
大消费品及其他3.52M0.36%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry966.35M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Overseas598.42M61.93%
Territory367.93M38.07%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More